New hope for patients Who've run out of options: experimental cancer drug enters human testing

NCT ID NCT06590961

Summary

This is the first study in people testing a new drug called UBX-303061 for patients with advanced B-cell cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also check if the drug shows any signs of shrinking tumors in these patients who have few other treatment options.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY B-CELL MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AidPort

    NOT_YET_RECRUITING

    Grodzisk Wielkopolski, Wielkopolskie Voivodeship, 62-065, Poland

  • Asan Medical Center

    RECRUITING

    Seoul, Seoul, 05505, South Korea

  • Gabrail Cancer Center

    RECRUITING

    Canton, Oklahoma, 44718, United States

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • MICS Centrum Medyczne Toruń

    NOT_YET_RECRUITING

    Torun, Kuyavian-Pomeranian Voivodeship, 87-100, Poland

  • Pratia, MTZ Clinical Research

    NOT_YET_RECRUITING

    Warsaw, Mazowieckie Voivodeship, 02-172, Poland

  • Pratia, Oncology Katowice

    NOT_YET_RECRUITING

    Katowice, Silesian Voivodeship, 40-519, Poland

  • Samsung Medical Center

    RECRUITING

    Seoul, Seoul, 06351, South Korea

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    RECRUITING

    Seoul, Seoul, 06591, South Korea

  • The Catholic University of Korea, Yeouido St. Mary's Hospital

    RECRUITING

    Seoul, Seoul, 07345, South Korea

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

Conditions

Explore the condition pages connected to this study.